Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Anti-bacterial and Anti-inflammatory Effects of Angelica dahurica Extracts in Helicobacter pylori-infected Human Gastric Epithelial AGS Cells

백지(Angelica dahurica) 추출물의 Helicobacter pylori에 대한 항균력 및 H. pylori로 유도한 염증반응에 대한 항염 효과

  • Received : 2018.08.28
  • Accepted : 2018.09.21
  • Published : 2018.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this study was to evaluate the anti-helicobacter activity and anti-inflammatory activity of Angelica dahurica (AD). The minimum inhibitory concentration(MIC) of AD against Helicobacter pylori(H. pylori), expression of the H. pylori cagA gene in the presence of AD was determined. Inhibition of H. pylori urease by AD, inhibition of nitric oxide (NO) production in AGS cells was measured. IL-8 mRNA expression in AGS cells which were infected with H. pylori and IL-8 level was measured. The MIC of MeOH Ex. of AD was $250{\mu}g/mL$ and the expression of cagA gene was decreased about 88% in the presence of AD. The activity of H. pylori urease was inhibited 70% by AD. mRNA expression of IL-8 and the production of NO and IL-8 were significantly decreased in the presence of AD. In conclusion, AD showed anti-Helicobacter activity and has potent anti-inflammatory effect on H. pylori-induced inflammation in human gastric epithelial AGS cells.

Keywords

References

  1. Kim, B. J. and Kim, J. G. (2015) Epidemiology and pathophysiology of Helicobacter pylori infections in Korea. Korean J. Med. 89: 133-141. https://doi.org/10.3904/kjm.2015.89.2.133
  2. Kathleen, R. J., Jeannette, M. W. and Scott, M. D. (2010) A tale of two toxins: Helicobacter pylori cagA and vacA modulate host pathways that inpact disease. Front. Microbiol. 1: 1-17.
  3. Hatakeyama, M. and Higashi, H. (2005) Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 96: 835-843. https://doi.org/10.1111/j.1349-7006.2005.00130.x
  4. Odenbreit, S., Puls, J., Sedlmaier, B., Gerland, E., Fischer, W. and Haas, R. (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287: 1497-1500. https://doi.org/10.1126/science.287.5457.1497
  5. Tegtmeyer, N., Wessler, S. and Backert, S. (2011) Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278: 1190-1202. https://doi.org/10.1111/j.1742-4658.2011.08035.x
  6. Kabamba, E. T., Tuan, V. P. and Yamaoka, Y. (2018) Genetic populations and virulence factors of Helicobacter pylori. Infect. Genet. Evol. 60: 109-116. https://doi.org/10.1016/j.meegid.2018.02.022
  7. Blaser, M. J., Perez-Perez, G. I., Kleanthous, H., Cover, T. L., Peek, R. N., Chyou, P. G., Stemmerann, G. N. and Nomra, A. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach Cancer Res. 55: 2111-2115.
  8. Crabtree, J. E., Wyatt, J. I., Trejdosiewiez, L. K., Peichl, P., Nochols, P. M., Ramsay, N., Peichl, P., Nicolson, P. H., Ramsay, N., Primrose, J. N. and Lindley, I. J. (1994) Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J. Clin. Pathol. 47: 61-66. https://doi.org/10.1136/jcp.47.1.61
  9. Kim, N. Y. (2003) Retreatment of Helicobacter pylori infection with triple therapy after initial treatment failure. Korean J. Gastroenterol. 42: 195-203.
  10. Francesco, V. D., Zullo, A., Hassan, C., Giorgio, F., Rosania, R. and Ierardi E. (2011) Mechanisms of Helicobacter pylori antibiotic resistance. An updated appraisal. World J. Gastrointest. Pathophysiol. 2: 35-41. https://doi.org/10.4291/wjgp.v2.i3.35
  11. Huang, H. L., Ko, C. H., Yan, Y. Y. and Wang, C. K. (2014) Antiadhesion and anti-inflammation effects of Noni (Morinda citrifolia) fruit extracts on AGS cells during Helicobacter pylori infection. J. Agric. Food Chem. 62: 2374-2783. https://doi.org/10.1021/jf405199w
  12. Moon, K. H., Park, P. B. and Jeong, W. Y. (2005) Inhibiton activity and charaterization of lactic acid bacteria from pig feces. KSBB J. 20: 76-82.
  13. Kwon, Y. S., Kobayashi, A., Kajiyama, S. I., Kawazu, K., Kanzaki, H. and Kim, C. M. (1997) Antimicrobial constituent of Angelica dahurica roots. Phytochemistry 44: 887-889. https://doi.org/10.1016/S0031-9422(96)00634-6
  14. Lechner, D., Stavri, M., Oluwatuyi, M., Pereda-Miranda, R. and Gibbons, S. (2004) The anti-staphylococcal activity of Angelica Dahurica (Bai Zhi). Phytochemistry 65: 331-335. https://doi.org/10.1016/j.phytochem.2003.11.010
  15. Li, D. and Wu, L. (2017) Coumarins from the roots of Angelica dahurica cause anti-allergin inflammation. Exp. Ther. Med. 14: 874-880. https://doi.org/10.3892/etm.2017.4569
  16. Kawase, M., Tanaka, T., Sohara, Y., Tani, S., Sakagami, H. Hauer, H. and Chatterjee, S. S. (2003) Structural requirements of hydroxylated coumarins for in vitro anti-Helicobacter pylori activity. In Vivo 17: 509-512.
  17. Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing, 19th Informational Supplement. CLSI, Wayne, PA, 2009. Document M100-S19.
  18. Weatherburn, M. W. (1967) Phenol-hypochlorite reaction for determination of ammonia. Anal. Chem. 39: 971-974. https://doi.org/10.1021/ac60252a045
  19. Warren, J. R. and Marshall, B. (1983) Unified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1: 1273-1275.
  20. Correa, P. and Piazuelo, M. B. (2008) Natural history of Helicobacter pylori infection. Dig. Liver Dis. 40: 490-496. https://doi.org/10.1016/j.dld.2008.02.035
  21. Kabamba, E. T., Tuan, V. P. and Yamaoka, Y. (2018) Genetic populations and virulence factors of Helicobacter pylori. Infect. Genet. Evol. 60: 109-116. https://doi.org/10.1016/j.meegid.2018.02.022
  22. Dupas, J. L. (2003) First line therapy for Helicobacter pylori eradication in France. Gastroenterol. Clin. Biol. 27. 467-472.
  23. Moradniani, M., Mirbeik-Sabzevari, Z., Jaferian, S., Shafiezadeh, S., Ardakani, M. J. E., Roozbahany, M. M., Azadbakht, S. and Sherkatolabbasieh, H. (2018) Levofloxacin based vs clarithromycin based sequential therapy in Helicobacter pylori eradication; a randomized clinical trial. Gastroenterol. Hepatol. Bed. Bench. 11: 20-26.
  24. Losurdo, G., Cubisino, R., Principi, M.B., Barone, M., Leandro, G., Ierardi, E. and Di Leo, A. (2018) Probiotics monotherapy for Helicobacter pylori: Systematic review and pooled data analysis. World J. Gastroenterol. 24: 139-149. https://doi.org/10.3748/wjg.v24.i1.139
  25. Park, H. S., Wijerathne, C. U. B., Jeong, H. Y., Seo, C. S., Ha, H. and Kwun, H. J. (2018) Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury. J. Ethnopharmacol. 216: 239-250. https://doi.org/10.1016/j.jep.2018.01.025
  26. Choi, S.S., Lee, H. K. and Chae, H. S. (2014) Synergistic in vitro photodynamic antimicrobial activity of methylene blue and chitosan against Helicobacter pylori 26695. Photodiagnosis Photodyn. Ther. 11: 526-532. https://doi.org/10.1016/j.pdpdt.2014.08.005
  27. Lee, Y. S. and Kim, N. W. (2011) Antioxidant activity and irritation test of extracts obtained from Angelica dahurica. Prev. Nutr. Food Sci. 16: 8-11. https://doi.org/10.3746/jfn.2011.16.1.008
  28. Kim, P. S., Lee, T. J., Kim, Y, H. and Kim, J. S. (2011) Antioxidative activities of Angelica dahurica Radix ethanol extract. JKAIS 12: 4378-4384.
  29. Sim, Y., Park, G., Eo, H., Huh, E., Gu, P.S., Hong, S. P., Pak, Y. K. and Oh, M. S. (2017) Protective effects of a herbal extract combination of Bupleurum falcatum, Paeonia suffruticosa, and Angelica dahurica against MPTP-induced neurotoxicity via regulation of nuclear receptor-related 1 protein. Neuroscience 340: 166-175. https://doi.org/10.1016/j.neuroscience.2016.10.029
  30. Lin, C. H., Chang, C. W., Wang, C. C., Chang, M. S. and Yang, L. L. (2002) Byakangelicol, isolated from Angelica dahurica, inhibits both the activity and induction of cyclooxygenase-2 in human pulmonary epithelial cells. J. Pharm. Pharmacol. 54:1271-1278. https://doi.org/10.1211/002235702320402125
  31. Kim, A. R., Lim, J. W., Kim, H. G. and Kim, H. Y. (2016) Supplementation with Angelica keiskei inhibits expression of inflammatory mediators in the gastric mucosa of Helicobacter pylori-infected mice. Nutr. Res. 36: 488-497. https://doi.org/10.1016/j.nutres.2015.12.017
  32. Jadhav, S. G., Meshram, R. J., Gond, D. S. and Gacche, R. N. (2013) Inhibition of growth of Helicobacter pylori and its urease by coumarin derivatives: Molecular docking analysis. J. Pharm. Res. 7: 705-711.